Pulmonary Rehabilitation Clinical Trials
2 recruiting trials for Pulmonary Rehabilitation. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pulmonary Rehabilitation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Saglik Bilimleri Universitesi (1), Istanbul Medipol University Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is traditional physiotherapy group (procedure, 1 trial), followed by yoga program, Hospital-based pulmonary rehabilitation.
Track Pulmonary Rehabilitation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis
Sarcoidosis is a multisystem disease, characterized by the formation of immune granulomas with various clinical symptoms depending on the involved organs, which can involve many...
Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
The investigators aimed to compare the home-based Pulmonary Rehabilitation with the hospital-based pulmonary rehabilitation in terms of pulmonary rehabilitation efficiency in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pulmonary Rehabilitation, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pulmonary Rehabilitation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pulmonary Rehabilitation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.